At first glance, the idea of Chelsea signing yet another center-back this summer sounds about as logical as buying a new umbrella in the middle of a drought. With enough defenders on the books to start their own Game of Thrones spin-off, the move seems excessive. But take a closer look, and you’ll see there’s method to the madness—and a transfer window quietly brewing with potential exits and medical reports longer than a Tolstoy novel.
Chelsea’s Center-Back Carousel: Who’s Staying On?
Levi Colwill is the rock Enzo Maresca is planning to build around. Young, composed, and distinctly uninjured (a rare quality in Cobham these days), he’s the kind of player you make untouchable—unless you’re playing Fantasy Premier League and forgot to set your team. Right behind him is Tosin Adarabioyo, a steady head and reliable locker-room DJ. He won’t be the star of the show, but every good squad needs its supporting cast.
Chelsea’s Medical Room: Now Featuring Wesley Fofana (Again)
Wesley Fofana’s fitness is becoming a plot twist no one asked for. At this rate, the only thing more recurring than his injuries is the hope he’ll someday be fit. The club, wisely, isn’t counting on him anymore—which explains the whispers of Chelsea targeting an elite defensive addition. Because depending on Fofana is like leaning on a cardboard cutout in a hurricane.
Chelsea’s Great Exodus: Who’s Packing Bags?
Axel Disasi’s future seems claret and blue (hello, Villa), while Chalobah and Badiashile are in the “sell-if-possible, keep-if-necessary” bargain bin. Renato Veiga, meanwhile, has more loan miles than a used Honda, and Anselmino and Sarr are queuing up for the same ticket.
So, Why Sign Another Defender?
Because despite the numbers, Chelsea might be left with two consistent center-backs come August. That’s not squad depth—it’s a recipe for late-game heartburn. So yes, Chelsea may yet dip into the market again. And when they do, don’t be surprised. Just hope this one can survive more than five matches without a scan.
For more sports updates, make sure to follow us on:
